Q&A with Ogilvy Health’s Andrew Schirmer
Ogilvy Health CEO and Med Ad News editorial advisory board member Andrew Schirmer shares his insight regarding various topics featured in the December 2019 magazine’s Agency Roundtable forum.
About Andrew Humphreys
This author has yet to write their bio.Meanwhile lets just say that we are proud Andrew Humphreys contributed a whooping 297 entries.
Entries by Andrew Humphreys
Top 50 Companies 2019: Notes & Methodology
Med Ad News editors rank and profile the world’s top 50 companies that generate revenue from healthcare products in this 33rd annual special report.
Introducing the Outcomes Creativity Index
The Outcomes Creativity Index (OCI) represents a ranking of pharmaceutical companies and brands according to creativity and innovation. The OCI is an aggregate score-based creative achievement representing these leading U.S. and international healthcare award shows: The Outcomes LLC/Med Ad News Manny Awards; Cannes Lions; LIA: Health & Wellness; Clio Health; The One Show; The MM&M Awards; The Global Awards; and The Creative Floor Awards.
Amgen 2019: Building capacity to innovate and grow
Amgen continues to set the stage for the future after a record-setting 2018, strengthening the company’s long-term ability to innovate, compete and grow.
GlaxoSmithKline 2019: Innovation, Performance, and Trust
GlaxoSmithKline’s three long-term priorities are designed to create long-term value for patients, consumers, and shareholders.
Johnson & Johnson 2019: Operation Pharma Growth
Johnson & Johnson management has outlined a strategy to deliver above-market, compound annual growth for the company’s pharmaceutical business through 2023.
Novartis 2019: Innovating for challenging healthcare issues
Novartis is investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs.
Roche 2019: Strength in numbers
Roche’s newer pharmaceutical products are generating stellar performances and have the company well-positioned for future growth.
Top 200 Medicines Annual Report 2019: The king of medicines
Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.
Lions Health 2019 Takeaways
The Cannes Lions International Festival of Creativity’s 2019 Health Track consisting of the Pharma Lions and Health & Wellness Lions occurred in June along the scenic French Riviera.
